Esomeprazole and omeprazole may well boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in elevated adverse effects such as drowsiness, although the medical relevance is low in many clients – monitor the individual for adverse effects (e. If individual are not able to resume their common oral medication https://medeusresearchchem.com/product-category/research-chemicals/